Oxford Nanopore Technologies plc (LON: ONT)
London flag London · Delayed Price · Currency is GBP · Price in GBX
98.25
-1.05 (-1.06%)
Jul 3, 2024, 10:39 AM GMT

ONT Company Description

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells.

The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing.

Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008.

Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

Oxford Nanopore Technologies plc
Country United Kingdom
Industry Biotechnology
Sector Healthcare
Employees 1,238
CEO Dr. Gurdial Singh Sanghera

Contact Details

Address:
Gosling Building
Oxford, OX4 4DQ
United Kingdom
Phone 44 84 5034 7900
Website nanoporetech.com

Stock Details

Ticker Symbol ONT
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB00BP6S8Z30

Key Executives

Name Position
Dr. Gurdial Singh Sanghera Co-Founder, Chief Executive Officer and Non-Executive Director
Timothy Cowper Chief Operating Officer and Director
Dr. James Spike Willcocks Chief Strategy Officer and Director
Prof. Hagan Bayley Ph.D. Co-Founder and Member of Technical Advisory Board
Nicholas Patrick Keher Chief Financial Officer and Director
Jordan Herman Senior Vice President and General Counsel
John Schoellerman Senior Vice President of Corporate and Business Development
Richard Compton Senior Vice President of Sales and Commercial Operations
Sara Agee Le Vice President of Global Marketing
Sarah Lapworth Senior Vice President of Global Human Resources